Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Puja Mehta and Rachel Chambers.
Puja Mehta
Connection Strength
2.942
Rachel Chambers
  1. JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk. Eur Respir J. 2020 09; 56(3).
    View in: PubMed
    Score: 0.904
  2. Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities. Lancet Respir Med. 2020 08; 8(8):822-830.
    View in: PubMed
    Score: 0.887
  3. Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe? Lancet Rheumatol. 2021 Jun; 3(6):e394-e395.
    View in: PubMed
    Score: 0.234
  4. Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. Lancet Infect Dis. 2021 07; 21(7):912.
    View in: PubMed
    Score: 0.233
  5. Thromboses and COVID-19: reducing inflammation in addition to thromboprophylaxis. Lancet Rheumatol. 2021 Mar; 3(3):e171-e172.
    View in: PubMed
    Score: 0.231
  6. Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma. Lancet Rheumatol. 2021 Jan; 3(1):e9-e10.
    View in: PubMed
    Score: 0.228
  7. B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? Lancet Rheumatol. 2020 Oct; 2(10):e589-e590.
    View in: PubMed
    Score: 0.224
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.